Development
By Sean Brodrick On December 19, 202211:17 AM Eastern
The Fed is hiking us into a recession.
Strategic Options
Subscription
By Jon D. Markman On December 19, 202206:30 AM Eastern
Technology and other growth stocks were stronger than the broader markets on Friday, yet the Nasdaq Composite still slipped to 10,705, a closing loss of 1.0%. For the week, the benchmark Nasdaq...
By Tony Sagami On December 16, 202204:00 PM Eastern
The good news is that inflation is cooling down. This means you should continue to hold all positions, but here’s an update on 3 of them.
By Jon D. Markman On December 16, 202202:28 PM Eastern
Stocks resumed their slide Friday as investors acted on their concern that the Federal Reserve’s resolve.
By Sean Brodrick On December 16, 202212:00 PM Eastern
Take gains & buy winners as the Fed shuffles on rate hikes.
The consumer spending report dampened the market Thursday. Luckily, this comes just as December options expire.
Strategic Options
Subscription
By Jon D. Markman On December 16, 202207:30 AM Eastern
Stocks are falling again. The pundits are pessimistic. They warn that the worst is yet to come.
Investors should be wary. If you want to make real money in the stock market, you're better off...
Strategic Options
Subscription
By Jon D. Markman On December 15, 202203:04 PM Eastern
A wave of central bank rate hikes drowned stocks across global financial markets Thursday.
By Jon D. Markman On December 15, 202212:47 PM Eastern
Here’s a look at the latest tech news and trends, the sector’s winners and losers and your portfolio positions.
Strategic Options
Subscription
By Jon D. Markman On December 15, 202206:30 AM Eastern
Medical researchers are using what they know about our immune system and computers to make startling advances. There has never been a better time for investors.
Shares of Moderna (MRNA) closed...